Kirsten Craven

Selecting an LC-MS system for quantitation of pharmaceutical drug development

Oct 29, 2024 | Blogs, Echo MS, Pharma, QTRAP / Triple Quad, ZenoTOF 7600 system | 0 comments

Read time: 2 minutes

Introduction

Drug development is a challenging process that requires diverse analytical solutions and the expertise of research scientists.

Within drug discovery confident go/no-go decisions need to be made as quickly as possible. Often, highly sensitive techniques are needed to accurately monitor concentrations of biomarkers, therapeutic candidates, and their metabolites. QA/QC laboratories need consistent performance everyday over many years.

Pharmaceutical quantitation solution guide

We understand you are busy, needing to prioritize running instruments, reporting results and managing your laboratory to meet deadlines. We created a solution guide to explain how SCIEX systems fit in the drug development pipeline to save you time evaluating options.

The guide covers bio/pharmaceutical quantitative assays from discovery to QA/QC, for large and small molecules. Discussing challenges regularly faced by scientists, along with potential solutions.

Download the guide >

What’s inside the guide?

The guide includes comprehensive chapters addressing multiple challenges and solutions regularly faced in drug development.

Discovery

Identify hits with accuracy and speed
Easily report results with end-to-end workflows
Measure molecular masses for small and large drug candidates

Development (Small and large molecules)

Acquire reliable and sensitive bioanalytical data
Perform studies with confidence using compliance-ready software
Get support from a team of dependable experts

Regulatory solutions

Minimize regulatory risk with complete system solutions
Ensure compliance for instruments through installation and maintenance qualifications
Reduce human error with user access levels

QA/QC and lot release

Quickly identify deviations from product specifications
Flexible system configurations that can be tailored to an ever-evolving regulatory landscape
Expert application and service support

Products

Discover systems at the forefront of quantitative performance
Benefit from compliance-ready software and trusted service partners
Ensure your results are the best they can be

Download the guide here >

Nitrosamines: Where are we now?

Nitrosamines are a large group of N-nitroso compounds that share a common functional N-N=O group. They are produced by a chemical reaction between a nitrosating agent and a secondary or tertiary amine. Back in 2018, nitrosamines suddenly found themselves in the spotlight when they were unexpectedly detected in medications for high blood pressure. Since then, they have been found in several other prescription medications, including those for heartburn, acid reflux and diabetes, resulting in manufacturers recalling some common medications.

Celebrating customer experience: Insights from SCIEX leaders

Introduction Customer Experience Day (CX Day) is a special occasion for SCIEX, celebrated every first Tuesday in October. It’s a day dedicated to recognizing the incredible value of our customers and the relentless dedication of our associates who strive to make...

PFAS analysis in food: a robustness study in sensitivity and stability

The combination of per- and polyfluoroalkyl substances (PFAS) testing, trace-level regulatory requirements and complex MS applications can be intimidating. In a recent webinar, now available on demand, SCIEX PFAS expert Craig Butt demonstrated how the new SCIEX 7500+ system can help make PFAS testing easier.

Posted by

Kirsten Craven

Kirsten Craven is the Senior Global Marketing Manager for Pharma global strategic marketing at SCIEX. In this role, she manages strategic marketing for the pharmaceutical industry. Kirsten spent the first part of her career working in laboratories across multiple industries before moving into product management, and most recently pharma marketing.

0 Comments